Haemonetics (HAE) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $74.14 +1.87%
Revenue Growth %: +2.3%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +2.3%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.99, $0.10 better than the analyst estimate of $0.89. Revenue for the quarter came in at $318.2 million versus the consensus estimate of $313.12 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Benchmark Reiterates Buy Rating on Cineverse (CNVS) Ahead of Q4 Results
- NXP Semiconductors names Mike Lucarelli as new investor relations head
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
